Theravance Biopharma is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases...
Read moreTheravance Biopharma is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases...
Read moreAnnual Revenue
$51.3M
Theravance Biopharma's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 1.3B. Over the last four quarters, Theravance Biopharma's revenue has grown by 11%. Specifically, in Q4 2022's revenue was $14.6M; in Q3 2022, it was $12.5M; in Q2 2022, it was $11.1M; in Q1 2022, Theravance Biopharma's revenue was $13.2M.